Given that the proportion of Kaede Green+ CD8 T cells in the tumor was not significantly increased with anti–PD-L1 Abs, our data are consistent with the enhanced responsiveness of the newly recruited cells rather than overt increases in the number of CD8 T cells trafficking into the tumor. The gene discussed is CD274; the disease is neoplasm.